原发于十二指肠的双重打击淋巴瘤1例报告
被引量:2
摘要
患者男,38岁,人院前20d无明显诱因出现腹胀、呕吐,呕吐物为胃内容物,无呕吐宿夜食物,无喷射性呕吐。无发热、咳嗽、呕血、黑便、腹痛、吞咽困难、头晕、心慌,在当地医院诊疗无明显好转。4d前行胃镜检查发现十二指肠占位性病变,给予禁食、胃肠减压、补液等对症支持治疗。
出处
《内科急危重症杂志》
2012年第5期315-316,共2页
Journal of Critical Care In Internal Medicine
参考文献5
-
1Swerdlow S, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon:IARC Press ,2008. 265- 266.
-
2Hutchison RE, Finch C, Kepner J, et al. Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons. Anna oncol,2000,11 suppl 1 : S35 - S8.
-
3Eberle FC, Salaverria I, Steidl C. et al. Gray zone lymphoma : chromosomal aberrations with immunophenotypic and clinical correlations. Mod Pathol,2011,24(12) : 1586-1597.
-
4Salaverria I,Siebert R. The grey zone between Burkitt's lymphoma and large diffuse large B-cell lymphoma from a genetics perspective. J Clin Oncol,2011,29 (14) : 1835-1843.
-
5黄慧,杨文萍.介于弥漫大B细胞淋巴瘤和伯基特淋巴瘤之间的未分类的B细胞淋巴瘤的临床病理诊断进展[J].临床与实验病理学杂志,2010,26(2):227-230. 被引量:6
二级参考文献7
-
1朱雄增.弥漫性大B细胞淋巴瘤研究进展[J].临床与实验病理学杂志,2005,21(3):262-265. 被引量:16
-
2苏学英,许霞,李甘地.弥漫性大B细胞淋巴瘤40例细胞病理学分析[J].临床与实验病理学杂志,2008,24(1):75-79. 被引量:6
-
3褚红娟,宋兰英,蒋会勇,陈愉,赵彤.MUM1蛋白在弥漫性大B细胞淋巴瘤中的表达及意义[J].临床与实验病理学杂志,2008,24(2):207-210. 被引量:3
-
4周倩,张正祥,施红旗,周航波,石群立,周晓军.散发性伯基特及伯基特样淋巴瘤临床病理分析[J].诊断学理论与实践,2008,7(6):633-636. 被引量:2
-
5翟勇平,刘海宁,周晓钢,于亚平,宋萍,李锋,史平,王学文.淋巴母细胞淋巴瘤28例临床病理分析[J].医学研究生学报,2009,22(4):390-393. 被引量:13
-
6杨文萍,朱才娣,宫丽平,吕蓓蓓,邹音,钟华生,肖强,吴艳,徐红艳,曾松涛,黄慧.儿童腹腔非霍奇金B细胞淋巴瘤的临床病理及免疫表型分析[J].中华病理学杂志,2009,38(11):759-764. 被引量:15
-
7孙琦,樊祥山.同时具有IGH-BCL2和MYC基因重排的B细胞淋巴瘤是一种在临床及病理特征上与伯基特淋巴瘤和弥漫性大B细胞淋巴瘤不同的侵袭性肿瘤[J].临床与实验病理学杂志,2011,27(8):859-859. 被引量:14
共引文献5
-
1李相勇.伯基特淋巴瘤的临床病理特征分析[J].中国医药导报,2012,9(32):112-113. 被引量:5
-
2张会来,马芹,付凯,王华庆.一种新的淋巴瘤亚型:bcl-2和myc易位的双击淋巴瘤[J].白血病.淋巴瘤,2012,21(12):712-715. 被引量:3
-
3许霞,王振考,郑丽端,潘华雄,聂秀.人类免疫缺陷病毒感染相关弥漫性大B细胞淋巴瘤2例临床病理观察[J].诊断病理学杂志,2015,22(11):677-681.
-
4范丹丹.双重打击淋巴瘤的临床特征和治疗探讨[J].中国处方药,2016,14(9):135-136.
-
5郑少秋,罗敬,朱文标,陈会林,谢寿城,黄艳芳.梅州地区胃肠道B细胞淋巴瘤临床病理学研究[J].广州医科大学学报,2017,45(2):75-78.
同被引文献53
-
1Swerdlow S, Campo E, Harris N, et a1. WHO classification of tumors of hematopoietic and lymphoid tissues. Lyon: IARC, 2008: 15.
-
2Campo E, Swerdlow SH, Harris NL, et al. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood, 2011, 117: 5019-5032.
-
3Giulino-Roth L, Cesarman E. Molecular biology of Burkitt lymphoma. N"w York: Springer, 2013: 211-226.
-
4Quintanilla-Martin"z L, de long D, De Mascarel A, et a1. Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the X N meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, Franc".J Hematopathol, 2009, 2: 211-236.
-
5SaidJW. Aggressiv" B-celilymphomas: how many categories do we need. Modern Pathol, 2013, 26: 42-56.
-
6Hummel M, Bentink S, Berger H, et a1. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N EnglJ Med, 2006, 354: 2419-2430.
-
7Sietse M, Reiner S, Ed Schuuring ED, et al. Double-hit B cell lymphomas. Blood, 2011, 117: 2319-233l.
-
8Kluin PM, Harris NL, Stein H, et a1. B-celilymphoma, unclassifiahle, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. Lyon: IARC, 2008:265-266.
-
9Rob"rt P, German 0, Elenitoba-Johnson, et a1. Commentary on the WHO classification of tumors of lymphoid tissues (2008): "Gray zone" lymphoma. overlapping with Burkitt lymphoma or classical Hodgkin lymphoma.J Hematopathol, 2009, 2: 89-95.
-
10Franziska C,Jaime R, Wei L, et a1. Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal Iarge B-cell lymphoma. Haematologica, 2011, 96: 558- 566.
-
1陈玮,张岚,张秀莲,张伟华.双重打击淋巴瘤一例[J].白血病.淋巴瘤,2016,25(5):310-311.
-
2龚格格(综述),李玉富(审校).灰区淋巴瘤诊断及治疗的研究进展[J].白血病.淋巴瘤,2013,22(9):568-571. 被引量:1
-
3窦立萍(综述),于力(审校).灰区淋巴瘤的诊断及治疗进展[J].国际输血及血液学杂志,2009(3):252-255. 被引量:1
-
4董菲(综述),克晓燕(审校).原发纵隔B细胞淋巴瘤研究进展[J].白血病.淋巴瘤,2012,21(4):243-245. 被引量:3
-
5倪梵,钱素英,郑翠苹,童向民.MYC/BCL-2双重打击淋巴瘤研究进展[J].浙江医学,2016,38(22):1855-1859. 被引量:2
-
6李俊波,刘艳艳.双重打击淋巴瘤研究进展[J].白血病.淋巴瘤,2015,24(5):314-317. 被引量:3
-
7范丹丹.双重打击淋巴瘤的临床特征和治疗探讨[J].中国处方药,2016,14(9):135-136.
-
8周萍,刘平,石远凯.双重打击淋巴瘤研究进展[J].中华医学杂志,2014,94(8):633-634. 被引量:1
-
9李春蕊(综述),周剑峰(审校).双重打击淋巴瘤研究进展[J].国际输血及血液学杂志,2011,34(1):37-40.
-
10白聪,李敏,刘翠苓,高子芬,黄欣,徐菁.弥漫大B细胞淋巴瘤myc、bcl-2和bcl-6蛋白表达与基因异常的相关性研究[J].白血病.淋巴瘤,2017,26(3):152-155. 被引量:3